MedPath

Neurophysiologic Maturation Index for Moderate and Late Preterm Infants

Conditions
Neurophysiologic Maturation
Interventions
Other: Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition
Registration Number
NCT02156817
Lead Sponsor
Brown University
Brief Summary

Moderate and late preterm infants contribute to significant neonatal intensive care unit health care resource utilization because of their sheer numbers. Determinants of the length of hospitalization (LOH) in this population are understudied. Gestational age (GA) is used most commonly as a predictor for LOH but there are many limitations including inaccurate dating and morbidities of prematurity which at least partly related to neurophysiological immaturity. The latter can be assessed by amplitude integrated electroencephalogram (aEEG, a simplified 5 lead EEG), and possibly by heart rate variability (HRV) and respiratory variability (RV). All 3 are non-invasive tests that can be done at the bedside. Our study hypothesis is to determine if neurophysiologic maturation as assessed by aEEG, HRV and RV within 24-96 hours following birth improves the correlation between gestational age and length of hospitalization compared to gestational age alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
171
Inclusion Criteria
  • Gestational age of either 320-326 weeks or 340-346 weeks by Obstetric criteria (presence of a sure LMP or sonogram performed in the first trimester, or agreement between LMP and a sonogram performed between the first trimester and 20 weeks)
  • Admitted to a NICU of a participating institution
  • Post-natal age less than 96 hours
Exclusion Criteria
  • Major congenital anomaly/genetic anomaly
  • Growth restriction (birth weight < 10%, Fenton growth curves)
  • Unsure obstetric dating (e.g., absence of a sure LMP without a sonogram, earliest sonogram performed after 20 weeks without a sure LMP, or discrepancy between LMP and sonogram)
  • Exposure to medications within the preceding 12 hrs which may affect CNS function (e.g., fentanyl, morphine, midazolam)
  • Neonatal seizures
  • Neonatal abstinence syndrome secondary to in-utero exposure to narcotics, methadone etc, or at high risk for development of abstinence
  • Hypoxia-ischemia defined as the combination of fetal acidemia (cord gas or blood gas within 1 hour of birth: pH ≀ 7.15 or BE β‰₯ -10mEq/L), need for resuscitation at birth (PPV Β± chest compressions or medications), and evidence of encephalopathy (Stage 1, 2 or 3 Sarnat). Stage 1 encephalopathy will be defined based on the level of consciousness which is characterized by a hyper-alert state, apparent alertness, and irritability. In the absence of a cord or early post-natal blood gas, there must be a history of a perinatal event which may have compromised oxygenation or blood flow to the fetus.
  • Infants who are expected to be on mechanical (via an endotracheal tube) or high frequency ventilation for the first 96 hours after birth.
  • Inability to obtain the informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Late Preterm Infants (LPT)Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition34 weeks and 0-6 days gestational age
Moderate preterm infants (MPT)Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition32 weeks and 0-6 days gestational age
Primary Outcome Measures
NameTimeMethod
Magnitude of variance, R square2 years

linear regression model: LOH = intercept + b1GA + b2aEEG + b3HRV + b4RV + error term; b1 - b4 represents the weight of each variable to explain the variance of the equation (R2), GA is gestational age, aEEG is amplitude integrated EEG, HRV is heart rate variability, RV is respiratory variability, LOH is length of hospital stay

Secondary Outcome Measures
NameTimeMethod
Amplitude integrated electroencephalogram (aEEG)participants will be followed for the duration of hospital stay, an expected average of 5 weeks

number of cycles/hour, the lower border voltage, the span voltage or the percent of the tracing which is discontinuous

Respiratory variability (RV)participants will be followed for the duration of hospital stay, an expected average of 5 weeks

instantaneous respiratory effort, phase between ribcage and abdomen, amplitude of the signal, pause metrics and movement artifact metrics

Heart rate variability (HRV)participants will be followed for the duration of hospital stay, an expected average of 5 weeks

standard deviation of the R-R interval, sample asymmetry and sample entropy

Trial Locations

Locations (3)

McGill University Health Center

πŸ‡¨πŸ‡¦

Montreal, Quebec, Canada

Wayne State University

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

Brown University - Women and Infants Hospital of Rhode Island NICU

πŸ‡ΊπŸ‡Έ

Providence, Rhode Island, United States

Β© Copyright 2025. All Rights Reserved by MedPath